The infectious bursal disease (IBD) causes immunosuppression in chicken of all ages and high mortality in young chicken, posing serious threat to poultry industry worldwide. One promising strategy for preventing this highly contagious disease is using recombinant subunit vaccine, employing VP2 subviral particles (SVP) as epitomic antigen. Analytical techniques of viral-like particles such as SDS-PAGE, western blot, or high-performance size-exclusion chromatography have been widely applied, but mostly unsatisfactory. In the present study, a simple, fast and cost-effective capillary zone electrophoresis (CZE) method with UV-detection was developed to analyze purified IBDV-SVP (expressed by Escherichia coli system) using commercial monoclonal antibody (mAb) against VP2. To find satisfying CZE conditions, injection mode, separation voltage, and separation buffer were explored. Through the modified CZE, mAb and SVP could be well separated and shown distinct peaks in the electropherogram. Furthermore, to determine the stoichiometry, the area of the mAb peak versus SVP/mAb binding ratio was plotted and indicated that 2 or 3 receptor molecules were bound per SVP. The purity and integrity of SVP and the interactions between SVP and mAb could be analyzed by the developed simple CZE-UV method in less than half hour. This CZE-UV method proved to be a valuable and useful tool in detection, characterization, and quantification of IBDV-SVP and the mAb, offering potential applications of in-process quality control of vaccine production, surveillance of serum antibody produced against IBDV infection, or vaccine immunization.
INTRODUCTION
Infectious bursal disease virus (IBDV) is a nonenveloped icosahedral virus, belonging to the family Birnaviridae. IBDV poses a considerable threat to the poultry industry worldwide by causing highly contagious and fatal infectious bursal disease (IBD), or immunosuppression that renders chicken susceptible to secondary opportunistic bacterial infection. (Kibenge et al., 1988; Berg, 2000) Thus far, there is no treatment to IBD, and the only practical and essential way to control IBD is by administration of either live or inactivated IBDV vaccines. The former provides lifelong protection, but potentially causing bursa damage and the schedule of vaccination is challenging due to the interference of maternal immunity. The latter cannot achieve C 2018 Poultry Science Association Inc.satisfactory protection when the hypervirulent strains emerged. (Berg, 2000) An alternative way is the subunit vaccine, which produces safer and more effective prevention and control of very virulent strains of IBDV. Different expression systems like Escherichia coli (Rong et al., 2005; Jiang et al., 2016) , yeast (Macreadie et al., 1990) , bacteriophages (CAO et al., 2005) , baculovirus (Vakharia et al., 1993) , and bamboo mosaic virus (Chen et al., 2012) have all successfully produced VP2 subviral particle (SVP), which contains conformational dependent epitopes that are responsible for eliciting neutralizing antibodies (Müller et al., 1992) . Vaccination of experimental chickens with these expression products has demonstrated various levels of protection against mortality or bursal damage. Among all expression systems, bacterial expression system is quick, inexpensive, and less-laborious. However, since the lack of a quick and simple method to evaluate the quality and consistency of the recombinant products, the subunit vaccine has not been commercially available yet. Virus-like particles or SVP produced by controlled expression systems must go through proper quality control (QC) assays and be well characterized prior to in vivo studies. This study aims to develop a simple, more rapid, and costeffective analysis system for monitoring the integrity and purity of the recombinant proteins and for QC of the final subunit vaccine.
High-performance size-exclusion chromatography, sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), and western blot are widely applied to determine the stability and purity of protein and polysaccharide vaccines. (Rong et al., 2005; Hahne et al., 2014) These methods are common, easyto-learn, and available in many laboratories, and yet they are time-consuming, semi-quantitative, or with low sensitivity. In contrast, capillary electrophoresis (CE) can compensate for the difficulties encountered by the methods above, providing high resolution, automated operation, and small amount of samples requirement. (Kremser et al., 2007) Capillary zone electrophoresis (CZE), the simplest form of CE, differentiates charged analytes on the basis of mobility under the influence of constant electric field. When in solution, the amino acid residues of the constituent polypeptides can generate electrical charge to the virions. The virus or subviral particles can flow in an electric field and then be separated by electrophoresis. CZE could be used as a straightforward in-process testing to assure the consistency through whole procedure of vaccine production. Furthermore, the interactions between antibody and virus or viral particle have be analyzed affinity CE (ACE) in many studies as well (Okun et al., 2000; Kremser et al., 2006) .
The goal of the present study is to develop the CZE-UV method to detect and analyze IBDV-VP2 made by E. coli expression system, the monoclonal antibody (mAb) against VP2, and the complex of IBDV-VP2 and mAb. To our knowledge, this is the first CE method developed specially for detection of IBDV-VP2 and its binding relationships to monoclonal antibody.
MATERIAL AND METHODS

Buffers Preparations
Three different background electrolytes (BGE) each made in four pHs (pH 1.0, 3.0, 7.0, and 9.0) were tested for selecting satisfying CZE condition. First, phosphate-buffered saline solution (PBS) was made up of 137 mM NaCl, 2.7 mM KCl, 2 mM KH 2 PO 4 , and 10 mM Na 2 HPO 4 . Second buffer consisted of 10 mM sodium deoxycholate, 10 mM sodium phosphate with 10 mM SDS. Third buffer was 50 mM borate buffer. Hydrochloric acid (0.1 M) or sodium hydroxide (0.1 M) was used to adjust the buffers into suitable pH. All solutions were made with deionized-distilled water and filtered through 0.45 μm filters prior to use.
Expression and Purification of IBDV-VP2
The very virulent infectious bursal disease virus (vvIBDV) TWN strain was kindly provided by Dr. Shien, Jui-Hung from the Department of Veterinary Medicine, National Chung Hsing University, Taiwan. VP2 of IBDV was amplified by reverse transcription polymerase chain reaction (RT-PCR) protocols described in by Liao (2013) . RT-PCR products were then separated and purified by agarose gel electrophoresis and FavorPrep Gel Purification Mini Kit (Favorgen, Pintung, Taiwan). The VP2 fragment was cloned into pTriEx-3 vector (Novagen) to generate pTri/VP2. pTri/VP2 was transformed into Rosetta 2 (DE3) pLacI competent cell (Novagen), and the expression of VP2 was induced with 0.5 mM isopropryl β-D-1-thiogalactopyranoside at 20
• C with shaking for 16 h. E. coli cells were centrifuged at 16,630 g, and the pellet was resuspended in PBS buffer with lysozyme. The mixtures were sonicated for 10 min and centrifuged. The supernatant containing VP2 proteins was purified following acid precipitation by PBS (pH 4.0), dialysis, and the sucrose gradient, as described (Liao, 2013) . The purity of SVP was assessed by SDS-PAGE, western blotting, and transmission electron microscope (TEM).
Capillary Zone Electrophoresis
P/ACE MDQ Capillary Electrophoresis System (Beckman Coulter, Fullerton, CA, U.S.A.) equipped with UV detector was used, employing a fused-silica capillary of 30 cm effective length (40 cm total length) and 75 μm inner diameter (Agilent Technology, CA, U.S.A.). Capillary was thermostated at 25
• C and set at the positive polarity mode with 18 kV voltage and UV 214 nm for detection throughout the experiments. Hydrodynamic injection was performed at 3.45 kPa for 3 s. Between all runs, the capillary was conditioned by 1 M NaOH, DDW, 1 M HCl, and the separation buffer for 5 min each. The BGE used for separation was 50 mM borate buffer (pH 9.0). Data were collected and analyzed using 32 Karat version 7.0 software (Beckman Coulter, U.S.A.), and electropherograms were exported through SigmaPlot 10.0 (Systat Software Inc.).
Quantification of Concentration of SVP and mAb
The concentrations of isolated and purified VP2 were determined by using commercial colorimetric assay kit. Bovine serum albumin (New England BioLabs, U.S.A.) was diluted with PBS into concentration of 20, 40, 80, 160, 320, 640 μg/mL and used as standard. BioRad protein assay (Bio-Rad, Taipei, Taiwan) was applied following the instructions to measure total concentrations of purified VP2. The absorbance was read at 595 nm. Each bovine serum albumin sample and VP2 sample was analyzed in triplicates.
Five different concentrations of VP2 samples in the range of 30 μg/mL to 250 μg/mL were prepared by serial dilution with PBS and analyzed through CZE to construct a 5-point calibration curve (peak area versus concentration). The level range of anti-VP2 mAb standards was 1.1 to 35.2 μg/mL. The standard deviation of mean (SEM) of all repeated measurements above was less than 11%. The equation for the calibration curves was Y = 394575X -8708 (R 2 = 0.99) for VP2 and Y = 7432.6X -16336 (R 2 = 0.98) for mAb. Each sample was then analyzed in triplicates. All statistical analyses were performed using analytic software (IBM SPSS Statistics 20, U.S.A.).
Interaction Between SVP and mAb
To find out the appropriate incubation time of SVP and Mouse monoclonal anti-IBDV (92) VP2 immonoglobulin G (HyTest, Turku, Finland), mixtures of SVP and mAb were analyzed by CZE 3, 5, 10, 20, 30, and 40 min after incubation in PBS at room temperature. For evaluation of the immunoaffinity interaction between SVP and mAb, designated concentrations of SVP (10 to 100 μg/ml) and a constant amount of mAb (100 μg/ml), representing SVP/mAb ratios of 0.1, 0.2, 0.4, 0.6, 0.8, and 1.0, were premixed in a microvial for 20 min before CZE analysis. The CZE conditions were as previously described.
RESULTS AND DISCUSSION
To evaluate the integrity and the purity of the SVP used in the study, SDS-PAGE (Figure 1a ), western blot (Figure 1b) , and TEM ( Figure 1c) were performed. These are common and traditional methods to analyze products of expression systems. (Jiang et al., 2016; Macreadie et al.,1990 ) Based on the stability of IBDV over a wide range of pH (Kibenge, Dhillon and Russell, 1988) , acidic PBS (pH 3.95) was initially used to precipitate non-VP2 proteins. Following the dialysis and sucrose-gradient centrifugation, contaminant proteins were decreased. A clear band presumably purified VP2 was found at 42 kDa in the electropherogram of SDS-PAGE. Since the molecular weight was much lower than the 48 kDa and 50 kDa reported previously (Jiang et al., 2016; Omar, et al., 2006) , the band was further confirmed through western blot by anti-VP2 monoclonal antibody. The variation in size can be attributed to the high variety of VP2 region in vvIBDV strains, and the construction of the vector also varied from different expression systems (Letzel et al., 2007) . Under electron microscopy, well-structured and self-assembled T = 1 SVP (≈25 nm) was found intact and quite uniform. The morphology was similar to the one reported by Jiang (Jiang et al., 2016; Wang et al., 2016) . This E. coli expression system and purification procedures proved to be appropriate in making VP2 in correct conformation.
In order to find satisfying CZE condition, several experiments were performed to construct optimal analytical conditions, such as separation buffer, separation voltage (5 kV and 18 kV), injection mode, and wavelength of UV detector (200 and 214 nm). Electrokinetic injection (10 kV) and pressure injection (3.45 kPa) were tested for 5 to 30 s. According to the study, when the sample was injected hydrodynamically at 3.45 kPa for 3 s by borate buffer (pH 9.0) applying a voltage of 18 kV, satisfactory peaks of SVP and mAb were produced (the isoelectric point for IBDV-VP2 is at pH 5.03 and for IgG is mostly <pH 9.0) under UV detection at 214 nm. Single peak of SVP (MW ≈ 42 kDa) was observed at 5.65 min, and mAb (MW ≈ 150 kDa) peak was observed at 4.69 min (Figure 2a) . The findings confirmed the usefulness of CZE-UV system as a tool to quantify both purified SVP and mAb. In the traditional gel electrophoresis system, the lighter SVP might appear earlier than the mAb, which is a globulin. However, it was vice versa in the CZE analysis due to the fact that CZE separates samples by the charge to mass ratio rather than solely by the molecular weight (as in the gel electrophoresis). The 1-min time difference between SVP and mAb in CE setting presented a favorable condition for the detection of SVP-mAb complex in ACE.
In order to facilitate the use of develop method to characterize SVP, ACE was further developed to study the complex formation of SVP and mAb, such that the SVP-mAb complex can be identified in a direct approach. According to the high affinities and selective nature between antigens and antibodies, nonequilibrium ACE was applied instead of the equilibrium method. (Kremser et al., 2007) The appropriate incubation time to reach equilibrium between the analyte and ligand can be established prior to electrophoresis. The time to reach equilibrium was determined by analysis of SVP-mAb mixtures at various length of incubation time. The area of the peak of the complex versus incubation period was shown in Figure 2c . The peak shape (data not shown) and the migration time maintained at similar level from 20 to 40 min, so the combination of antigen and antibody was assumed to saturate after 20 min of incubation. Formation of antigen-antibody (Ag-Ab) complex results in a change in size, shape, and charge compared to the free particle, which influences the electrophoretic mobility. In this case, the mobility of complex lays intermediate to that of the reacting components (SVP and mAb). The affinity interaction between SVP and mAb was demonstrated in Figure 2a . When increasing amount of SVP was incubated with a constant amount of mAb, the mAb peak decreased accordingly with the emergence of a new peak correlating to the Ag-Ab complex. At [SVP] to [mAb] ratio of 60:100, the peak of mAb totally disappeared. It is interesting to note that while SVP concentration kept increasing, the complex peak became sharper and the migration time prolonged, and the migration time varied from 4.80 to 5.34 min. Based on the sharp and clear peak shape of the SVP-mAb complex, the interaction between SVP and mAb was stable, which again supported the nonequilibrium ACE. (Heegaard, 1994) For determination of the stoichiometry, a linear relationship between interaction ratios and the area of mAb peak could be constructed (Figure 2b ). The intercept with the x-axis from the linear extrapolation of the curve, indicated that the ratio of [SVP]/[mAb] (concentration in parts per million) was 42:100 (x = 0.42). When the area of mAb peak equals zero, it suggested that no more free receptors was available on the mAb for particle binding. Now if we divided the concentration by their molecular weight, the stoichiometry of mAb and SVP was calculated to be 2:3, which implied that two molecules of mAb were bound to three molecules of SVP. This deduction was desirable in understanding the binding behavior because a complex like this may not simply form by one molecule of mAb bound with one molecule of SVP, despite there are two receptor-binding sites on the mAb, IgG, and also two epitopes on the SVP (Müller et al., 1992) . One research reported that the stoichiometry derived from ACE analysis of IgG and 8F5-HRV2 was well correlated with the topology findings by cryoelectron microscopy (Okun et al., 2000) . While there were no cryoelectron microscopy images of SVP-mAb available, it is feasible to assume that stoichiometry of SVP and mAb could be obtained from a simpler ACE method as developed in the current study.
VP3 is another IBDV structural protein, which is considered a non-protective antigen. The electropherogram in the current study suggested that commercial monoclonal antibody against IBDV-VP3 could be separated from the SVP formed by IBDV-VP2, indicating sufficient specificity and purity of the produced SVP (unpublished data). Moreover, this feature may help to distinguish the subunit-vaccine vaccination from the field infection because immunization of subunit vaccine only induced antibody against VP2, while both anti-VP2 and anti-VP3 antibodies are produced in the field infection. (Maas et al., 2004) In summary, a simple and effective CZE-UV method for analysis of IBDV-SVP (expressed by E. coli system) and its mAb was established. The short run time, low sample amount, and automation are advantages of CZE, making it a possible way for in-process QC of IBDV subviral particles for subunit vaccine production and for the surveillance of serum antibody produced against IBDV infection or vaccine immunization. Further investigation on commercial vaccine, in-house subunit vaccine, and serum of chicken is warranted.
